Streptococcus pneumoniae causes acute bacterial infections. The bacterium, also called
pneumococcus, was first isolated by Louis Pasteur in 1881 from the saliva of a patient with …

This report updates the last recommendations by the Advisory Committee on Immunization
Practices (ACIP) concerning pneumococcal polysaccharide vaccine (MMWR 1989; 38: 64-8 …

There are comparatively little data on the incidence and morbidity from pneumococcal
disease in Australia and elsewhere. Available data suggest that the overall incidence of …

The pneumococcus (Streptococcus pneumoniae) is a major cause of pneumonia, otitis
media and meningitis throughout the world. Although the mortality resulting from …

This chapter focuses on the epidemiology of pneumococcal disease in terms of pathogen
characteristics and host risk factors. The clinical manifestations of Streptococcus …

Pneumococcal vaccination : Current Opinion in Infectious Diseases Pneumococcal vaccination
: Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get …

Pneumococcal disease is a major cause of illness and death in the young, the elderly, and
those with certain medical conditions. Pneumococcal conjugate vaccines are changing both …

A 23-valent polysaccharide vaccine against disease caused by Streptococcus pneumoniae
(pneumococcus) was licensed in the United States in 1983. It replaces the 14-valent …

Population-based prospective surveillance of invasive pneumococcal disease was done in
Southern California from 31 March 1992 to 1 April 1995; 814 cases were identified, for an …

Use of the heptavalent pneumococcal conjugate vaccine has led to a major decline in the
prevalence of invasive pneumococcal disease (bacteremia, meningitis) and a more modest …